Jack Weinstein Email & Phone Number

Geneve, Ch

• Member of senior management team of this publicly traded Swiss and US biopharmaceutical company focusing on the development of therapies to treat rare diseases with high unmet medical needs.• Supervised the establishment of a US commercial team, launched first US commercial product.• Executed reverse stock split to increase attractiveness of stock to institutional investors.

Geneve, Ch

• Raised $85 million in equity on favorable terms.• Executed two acquisitions and in-licensed two products, transforming Relief from a development stage to a commercial stage biopharmaceutical company.• Responsible for all investor and investment banking outreach, while managing all internal financial activities.

Sunnyvale, California, Us

Provide strategic, operations and “CFO” consulting services, including merger and acquisitions advisory, budgeting, and raising public and private equity and debt for middle-market companies.• Developed relationships with overseas manufacturers for healthcare client working on a large IP licensing deal and training contract to tie-in with manufacturer’s product line.• Introduced celebrity branding start-up to entertainment executive that is spearheading development and go-to-market strategy for company.• Negotiating licensing agreement for biopharmaceutical client; developed business plans that helped secure interest from specialty pharmaceutical company.• Created acquisition strategy for environmental services client; introduced client to potential high-volume, multi-site customer for a series of high-level negotiations.• Established financial infrastructure and systems for start-up client and introduced company to a pipeline of potential new accounts.• Performed due diligence, prepared financial projections and made acquisition proposal for jewelry retailer.• Spearheading equity funding for digital media company; created presentation decks and executive summary.Mr. Weinstein holds FINRA Series 79 and 63 Licenses.

Coral Gables, Florida, Us

• Executed successful Nasdaq Global Market IPO (CPRX) and five subsequent registered direct common stock offerings.• Identified potential strategic partners and participated in discussions to out-license CPRX products and in-license new products.• Leveraged relationships with investment banks like First Albany (became Broadpoint Capital), Stifel Nicolaus, Roth Capital, Rodman & Renshaw, Merriman Curhan Ford for IPO and subsequent deals.• Recruited and developed Corporate Controller and Chief Accounting Officer; assisted CEO with the hiring of a VP of Regulatory Affairs.• Identified opportunity to enhance contact management and implemented proprietary system to streamline system and then migrate to Salesforce.com.• Instituted formal budgeting process integrated with Catalyst accounting system which helped control costs.• Identified strategic alliance in the UK and held high-level discussions with multi-national company.• Supervised development of Sarbanes Oxley and XBRL implementations; sourced SOX Consultant.• Hired and supervised the creation and management of Catalyst’s third and fourth generation of Web Sites at costs significantly less than market.• Replaced high-cost health plan with a high-deductible policy and self-insurance for deductibles.• Authored policies for finance, product liabilities, D&O and health insurance.

• Led successful rights offering, private equity placement and successful IPO for a pharmaceutical client.• Provided CFO services and support, fundraising and management consulting for client company.• Managed sourcing and execution of investment banking transactions.

Us

• Hired to start, staff and lead the Healthcare Investment Banking Group.• Raised company profile in the healthcare space through conference programming and interaction with healthcare analysts.• Managed sourcing and execution of investment banking transactions.

Transactions of note:Sole managed $20 million IPO for Ribogene (Questcor). Company sold in 2014 to Mallinckrodt for $5.6 billion.$20.5 million secondary public offering and two PIPEs ($12.4 million and $3.9 million) for LifeCell Corporation, a Gruntal and then Ladenburg client. Company sold in 2008 to Kinetic Concepts Inc. for $1.7 billion.$4.2 million PIPE for BEI Medical Systems. Company sold in 2002 to Boston Scientific for $95 million. $6.0 million PIPE for AVANIR Pharmaceuticals.Executed $20 million leveraged recapitalization of NFS, a recreational food services company.Advised MSE, a technology and environmental development company in sale of civil engineering business. Transaction value -- over $3 million.

Master Of Business Administration, Emphasis In Finance And Service Operations

Bachelor Of Music, Magna Cum Laude, Music Industry Management & Operations